Form 4: USANA Director Winssinger Converts RSUs to Stock

USANA Health Sciences Director Frederic J Winssinger converted 1,058 restricted stock units into common stock, increasing his direct beneficial ownership.

Summary

• Frederic J Winssinger, a Director at USANA Health Sciences Inc. (USNA), reported a change in beneficial ownership.
• On January 22, 2026, Winssinger acquired 1,058 shares of Common Stock through the conversion of Restricted Stock Units (RSUs).
• Following this transaction, Winssinger directly beneficially owns 7,044 shares of USNA Common Stock.
• The transaction was made pursuant to a Rule 10b5-1(c) plan.
• Each restricted stock unit represents a contingent right to receive one share of USNA common stock.
• Remaining Restricted Stock Units beneficially owned after the transaction total 1,057.
• The Restricted Stock Units vest 25% on July 24, 2025, October 23, 2025, January 22, 2026, and April 23, 2026.

Sentiment

Score: 5

Explanation: The filing reports a routine insider transaction related to equity compensation, which is neutral in sentiment. It does not contain information that would significantly alter the perception of the company's financial health or operational performance.

Positives

• The conversion of Restricted Stock Units into common stock increases the director's direct equity stake in the company, potentially aligning his interests more closely with shareholders.
• The transaction was conducted under a Rule 10b5-1(c) plan, indicating a pre-arranged and transparent transaction.

Future Outlook

The filing details a pre-scheduled insider transaction and does not provide forward-looking statements or guidance regarding the company's financial performance or strategic direction.

Industry Context

This Form 4 filing reports a routine insider transaction involving the conversion of equity compensation (Restricted Stock Units) into common stock. Such transactions are common across all industries as part of executive and director compensation plans and do not typically reflect broader industry trends or competitive positioning.

Related Party Transactions

• Frederic J Winssinger, a Director of USANA Health Sciences Inc., engaged in a transaction involving the company's securities, which is considered a related party transaction.

Stakeholder Impact

• Shareholders: The transaction represents a routine change in a director's beneficial ownership, which is generally not expected to have a significant direct impact on other shareholders. It slightly increases the director's direct stake, aligning interests.
• Employees: No direct impact on employees is indicated by this filing.
• Customers/Suppliers/Creditors: No direct impact on these stakeholders is indicated by this filing.

Next Steps

• Future vesting of remaining Restricted Stock Units on October 23, 2025, January 22, 2026, and April 23, 2026.

Key Dates

Keywords

USANA Health Sciences, USNA, Insider Transaction, Form 4, Restricted Stock Units, Common Stock, Beneficial Ownership, Director, Equity Compensation